INVESTIGATION OF BIOMARKERS ASSOCIATED WITH PATHOLOGICAL STAGE OF ESOPHAGEAL ADENOCARCINOMA BY INTEGRATING CO-EXPRESSION NETWORK AND DIFFERENTIAL METHYLATION ANALYSIS | |
Chen, Hua-Fei3; Li, Xiao-Feng3; Lan, Gang3; Huang, Li-Chao3; Zhai, Zhan-Qiang3; Zhu, You-Cai3; Wang, Wen-Xian4; Xu, Chun-Wei1; He, Xiao2; Du, Kai-Qi3 | |
刊名 | ACTA MEDICA MEDITERRANEA |
2022 | |
卷号 | 38 |
关键词 | Esophageal adenocarcinoma co-expression network transcriptomics methylation pathological staging |
ISSN号 | 0393-6384 |
DOI | 10.19193/0393-6384_2022_4_440 |
通讯作者 | He, Xiao(2559472903@qq.com) |
英文摘要 | Background: Esophageal adenocarcinoma (EAC) is a devastating disease which related to a poor prognosis. Although many efforts have been paid to investigate the progress of EAC, pivotal molecular mechanism involved in the treatment of different tumor stages remains to be demonstrated. Materials and methods: We employ weighted correlation network analysis (WGCNA) and chip analysis methylation pipeline to explore core molecules associated with pathological staging by integrating gene expression and methylation profiles. By constructing a co-expression gene network, we screen out a gene set whose co-expression patterns are related to advanced stages of EAC. Results: Genes affected by abnormal methylation status are recognized by comparing differential methylation sites between cancer tissues and adjacent tissues, which can be distinguished by methylation levels. Based on integrative analysis on epigenetics and transcriptomics, we identified ten co-expressed genes accompanied with differential methylation. Expression levels of 3 genes including EGR2, HOXD8, and RSPO3, are identified to be negatively correlated with methylation values and to be associated with different pathological staging of EAC. These key genes promote tumorigenesis and cell proliferation by altering transcription factors activity and Wnt signaling pathway. Conclusions: Our study provides new insights into discovering characteristic molecules for divergent stages of EAC, which helps to optimize treatment of variable stages. |
WOS关键词 | BARRETTS-ESOPHAGUS ; DNA METHYLATION ; CANCER ; GENE ; HYPERMETHYLATION ; PROLIFERATION ; PROGRESSION ; VALIDATION ; EXPRESSION ; DYSPLASIA |
WOS研究方向 | General & Internal Medicine |
语种 | 英语 |
出版者 | CARBONE EDITORE |
WOS记录号 | WOS:000884059600105 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/130313] |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | He, Xiao |
作者单位 | 1.Fujian Med Univ, Fujian Canc Hosp, Dept Pathol, Canc Hosp, Fuzhou 350014, Fujian, Peoples R China 2.Lishui Peoples Hosp, Dept Radiotherapy, Lishui 323000, Zhejiang, Peoples R China 3.Zhejiang Rongjun Hosp, Dept Thorac Dis Ctr, Jiaxing 314000, Zhejiang, Peoples R China 4.Univ Chinese Acad Sci, Chinese Acad Sci, Zhejiang Canc Hosp, Dept Chemotherapy,Canc Hosp,Inst Canc Res & Basic, Hangzhou 310022, Zhejiang, Peoples R China |
推荐引用方式 GB/T 7714 | Chen, Hua-Fei,Li, Xiao-Feng,Lan, Gang,et al. INVESTIGATION OF BIOMARKERS ASSOCIATED WITH PATHOLOGICAL STAGE OF ESOPHAGEAL ADENOCARCINOMA BY INTEGRATING CO-EXPRESSION NETWORK AND DIFFERENTIAL METHYLATION ANALYSIS[J]. ACTA MEDICA MEDITERRANEA,2022,38. |
APA | Chen, Hua-Fei.,Li, Xiao-Feng.,Lan, Gang.,Huang, Li-Chao.,Zhai, Zhan-Qiang.,...&Du, Kai-Qi.(2022).INVESTIGATION OF BIOMARKERS ASSOCIATED WITH PATHOLOGICAL STAGE OF ESOPHAGEAL ADENOCARCINOMA BY INTEGRATING CO-EXPRESSION NETWORK AND DIFFERENTIAL METHYLATION ANALYSIS.ACTA MEDICA MEDITERRANEA,38. |
MLA | Chen, Hua-Fei,et al."INVESTIGATION OF BIOMARKERS ASSOCIATED WITH PATHOLOGICAL STAGE OF ESOPHAGEAL ADENOCARCINOMA BY INTEGRATING CO-EXPRESSION NETWORK AND DIFFERENTIAL METHYLATION ANALYSIS".ACTA MEDICA MEDITERRANEA 38(2022). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论